Mometasone Furoate significantly reduces radiation dermatitis in patients undergoing breast radiation therapy:a double-blind randomized control trial in 120 patients

Dunn, Kerry and Hindley, Andrew and Wood, Lisa and Sanneh, Alison and Barber, David and Whitehead, Anne and Zain, Zakiyah (2013) Mometasone Furoate significantly reduces radiation dermatitis in patients undergoing breast radiation therapy:a double-blind randomized control trial in 120 patients. International Journal of Radiation Oncology - Biology - Physics, 87 (2 Supp). S115. ISSN 0360-3016

Full text not available from this repository.

Abstract

The most common acute side effect of patients receiving radiation therapy to the breast/chest wall is radiation induced dermatitis. Despite this, there is no accepted intervention to prevent or treat it. A previous study by Bostrom et al showed Mometasone Furoate (M) cream was superior to Diprobase (D) in a study of 50 breast cancer patients. We sought to repeat this study in a larger cohort of 120 patients.

Item Type:
Journal Article
Journal or Publication Title:
International Journal of Radiation Oncology - Biology - Physics
Uncontrolled Keywords:
/dk/atira/pure/subjectarea/asjc/3100/3108
Subjects:
ID Code:
70118
Deposited By:
Deposited On:
25 Jul 2014 09:16
Refereed?:
No
Published?:
Published
Last Modified:
21 Oct 2020 02:58